首页> 外文期刊>Acta biomaterialia >Controlled and extended drug release behavior of chitosan-based nanoparticle carrier.
【24h】

Controlled and extended drug release behavior of chitosan-based nanoparticle carrier.

机译:壳聚糖基纳米颗粒载体的受控和扩展药物释放行为。

获取原文
获取原文并翻译 | 示例
           

摘要

Controlled drug release is presently gaining significant attention. In this regard, we describe here the synthesis (based on the understanding of chemical structure), structural morphology, swelling behavior and drug release response of chitosan intercalated in an expandable layered aluminosilicate. In contrast to pure chitosan, for which there is a continuous increase in drug release with time, the chitosan-aluminosilicate nanocomposite carrier was characterized by controlled and extended release. Drug release from the nanocomposite particle carrier occurred by degradation of the carrier to its individual components or nanostructures with a different composition. In both the layered aluminosilicate-based mineral and chitosan-aluminosilicate nanocomposite carriers the positively charged chemotherapeutic drug strongly bound to the negatively charged aluminosilicate and release of the drug was slow. Furthermore, the pattern of drug release from the chitosan-aluminosilicate nanocomposite carrier was affected by pH and the chitosan/aluminosilicate ratio. The study points to the potential application of this hybrid nanocomposite carrier in biomedical applications, including tissue engineering and controlled drug delivery.
机译:控制药物的释放目前正在引起广泛关注。在这方面,我们在此描述嵌入在可膨胀层状硅铝酸盐中的壳聚糖的合成(基于对化学结构的理解),结构形态,溶胀行为和药物释放响应。与纯壳聚糖相比,随着时间的推移药物释放会不断增加,而壳聚糖-铝硅酸盐纳米复合载体的特点是控制释放和延长释放。药物从纳米复合颗粒载体释放的过程是通过将载体降解成具有不同组成的其单个组分或纳米结构而发生的。在层状基于铝硅酸盐的矿物和壳聚糖-铝硅酸盐纳米复合材料载体中,带正电的化学治疗药物与带负电的硅铝酸盐牢固结合,并且药物的释放缓慢。此外,壳聚糖-铝硅酸盐纳米复合载体中药物的释放方式受pH和壳聚糖/铝硅酸盐比的影响。这项研究指出了这种杂化纳米复合材料载体在生物医学应用中的潜在应用,包括组织工程和受控药物输送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号